Show
Sort by
-
- Journal Article
- A1
- open access
Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)
-
A multilocus technique for risk evaluation of patients with neuroblastoma
-
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
-
ArrayCGH-based classification of neuroblastoma into genomic subgroups
-
ArrayCGH based classification of neuroblastoma into genomic subgroups